§ 28. Mrs. Renée Shortasked the Secretary of State for Social Services if he is satisfied with the current regulations concerning the research and development programme of new drugs.
§ Mr. MoyleRequirements governing approval to clinical trials and marketing of drugs are kept under continual review to ensure that beneficial new drugs are made available as quickly as possible, having proper regard to human safety. A working party set up by the Committee on Safety of Medicines is currently reviewing the amount of scientific data required before clinical trials of drugs on humans can be allowed.